Martine Zimmermann - Sep 22, 2023 Form 3 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Director
Signature
By: /s/ Andrew Reardon For: Martine Zimmermann
Stock symbol
LGND
Transactions as of
Sep 22, 2023
Transactions value $
$0
Form type
3
Date filed
9/25/2023, 06:12 PM
Next filing
Jun 18, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney